H.R. 8823: Putting Patients First by Strengthening Provider Accountability in FECA Act
This bill, titled the "Putting Patients First by Strengthening Provider Accountability in FECA Act," proposes amendments to the Federal Employees’ Compensation Act (FECA) aimed at enhancing accountability among medical service providers. Here’s a summary of the key points of the bill:
Key Provisions
- Suspension of Payments: The Secretary of Labor would be given the authority to suspend payments to medical providers if they have been convicted of fraud. This could relate to:
- Fraud in connection with the Federal Employees’ Compensation Act.
- Fraud in any Federal health care benefit program.
- Fraud in any similar state health care program.
- Regulatory Authority: The Secretary of Labor is required to establish regulations that put this provision into effect, detailing how the suspension of payments would be managed.
- Effective Date: The changes made by this bill would apply to payments made to providers starting 180 days after the bill is enacted.
Essentially, if a medical provider is found guilty of fraud against certain health care systems, the Secretary would have the power to stop payments made to them under FECA, which covers compensation for federal employees injured at work. This aims to ensure that only accountable providers can receive payment for services rendered to federal employees.
Objective
The overall objective of the bill is to strengthen accountability measures within medical services provided to federal employees, thereby aiming to reduce fraudulent activities within the system. This is part of a broader effort to ensure that funds allocated for health care are used appropriately and that patients receive quality care from reputable providers.
Impact
The passage of this bill could potentially result in stricter oversight of medical providers that serve federal employees, especially those providers involved in requesting or receiving compensation through FECA. It promotes a system where fraud is penalized more transparently, potentially leading to an improvement in service quality for patients.
Relevant Companies
- UNH (UnitedHealth Group) - As a major health care company providing services and insurance, it could be affected by changes in regulations regarding payments and accountability practices within health care services.
- CVS (CVS Health) - CVS operates pharmacies and provides health services; therefore, it may also face impacts from increased scrutiny and compliance measures related to federal health care programs.
- HUM (Humana) - As a health insurance provider serving government programs, changes to accountability and fraud prevention measures could influence their operational procedures and reimbursements.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
4 actions
| Date | Action |
|---|---|
| Jun. 25, 2026 | Committee Consideration and Mark-up Session Held |
| Jun. 25, 2026 | Ordered to be Reported (Amended) by the Yeas and Nays: 33 - 0. |
| May. 14, 2026 | Introduced in House |
| May. 14, 2026 | Referred to the House Committee on Education and Workforce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.